Contact
QR code for the current URL

Story Box-ID: 1257591

faCellitate GmbH Franz-Volhard-Str. 5. 68167 Mannheim, Germany http://facellitate.com
Contact Ms Annette Flory +49 621 87753530
Company logo of faCellitate GmbH

faCellitate Appoints Industry Leader Heinz Schmid to Advisory Board

(PresseBox) (Mannheim, )
faCellitate GmbH, a leading innovator in defined surface coatings for life science consumables, is proud to announce the appointment of Heinz Schmid to its Advisory Board. A globally recognized expert in the life sciences industry, Schmid brings over three decades of leadership experience, including 19 years as Managing Director of Greiner Bio-One Germany and 13 years as CEO of the Bioscience Business Unit at Greiner Bio-One International GmbH.

With his deep industry knowledge and strategic insight, Schmid will play a pivotal role in guiding faCellitate’s growth and innovation roadmap, particularly in advancing technologies that support the future of stem cell therapies and 3D cell culture.

“It is a special honour to welcome Heinz Schmid to the faCellitate Advisory Board,” said Dr. Simon Widmaier, CEO of faCellitate. “His unparalleled expertise will be instrumental as we continue to redefine the standards for functional life science consumables. This appointment marks a significant milestone in our mission to empower researchers worldwide.”

“I am excited to join faCellitate’s Advisory Board and contribute to their mission of advancing life science research,” said Heinz Schmid. “faCellitate’s innovative approach and commitment to excellence align perfectly with my values. I look forward to supporting the team in driving impactful scientific progress.”

 

 

Website Promotion

Website Promotion

faCellitate GmbH

About faCellitate

faCellitate GmbH, a spin-off from BASF’s incubator Chemovator, is renowned for its groundbreaking BIOFLOAT™ technology, a next-generation solution for spheroid and 3D cell culture. With BIOINSTRUCT™ faCellitate recently launched a fully synthetic coating designed to transform the way human induced pluripotent stem cells (iPSCs) are cultured. faCellitate’s proprietary fully synthetic, polymer-based technology is revolutionizing how researchers approach cancer and stem cell research, drug discovery, toxicology, and regenerative medicine.

With a strong commitment to scientific excellence and innovation, faCellitate continues to expand its product portfolio, providing researchers with the most advanced tools for reproducible and high-impact research.

Media Contact:
faCellitate GmbH – Press Department
? Email: info@facellitate.com
? Phone: +49 621 877 5353 0
? Learn more: www.facellitate.com

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2026, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.